Full bibliography

Return to list of results

The Future Of Psychedelic Medicine Might Skip The Trip

RIS

Recommended format for most reference management software

BibTeX

Recommended format for BibTeX-specific software

Resource type
Web Page
Author/contributor
Title
The Future Of Psychedelic Medicine Might Skip The Trip
Abstract
A hallucinogenic experience may draw people to LSD and psilocybin, but the mental health industry believes there's a $50 billion opportunity in turning these compounds into safe at-home medications—without the ego-dissolving ride.
Website Title
Forbes
URL
https://www.forbes.com/sites/willyakowicz/2021/06/23/the-future-of-psychedelic-medicine-might-skip-the-trip-rick-doblin-bryan-roth-mindmed-darpa-maps/
Accessed
6/24/21, 12:07 PM
Language
en
Extra
Section: Vices
Citation
Yakowicz, W. (n.d.). The Future Of Psychedelic Medicine Might Skip The Trip. Forbes. Retrieved June 24, 2021, from https://www.forbes.com/sites/willyakowicz/2021/06/23/the-future-of-psychedelic-medicine-might-skip-the-trip-rick-doblin-bryan-roth-mindmed-darpa-maps/
Link to this record
https://bestbackgrounders.info/bibliography/KKSRAXZE